MedPath

Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters

Conditions
Infertility, Female
Cystic Fibrosis
Registration Number
NCT05029817
Lead Sponsor
Hadassah Medical Organization
Brief Summary

The main objective of this study is to assess the ovarian reserve of CF patients via measurement of AMH and AFC. Secondly, we aim to correlate between the ovarian reserve and demographic and clinical characteristics of these patients.

Outcomes measured will be levels of AMH and AFC, as compared to standard means in the general population. There is no need for a control group in this study since the standardized means of AMH and AFC in the general population are a more accurate comparable measure, which is based on data collected from large-scale populations, and thus accounts for confounding age factor in a more complete manner than can be obtained via a control group (Almog et al., 2011, La Marca et al., 2012, Penzias et al., 2020).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Female patients diagnosed with CF according to genetic testing.
  • Age 18-45 years old.
  • Routinely attended the CF Center at Hadassah Medical Center.
Exclusion Criteria
  • Refusal to participate in the study.
  • Age under 18 or above 45.
  • Use of hormonal contraceptives (for the purpose of AFC).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AMH levels24 hours

Levels of Anti-Mullerian hormone

Antral follicular countThrough study completion, an average of 1 year.

Antral follicular count as assessed by ultrasound

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hadassah Medical Organization, Jerusalem, Israel

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath